Skip to main content

Table 4 Correlation studies of MPO level with the other studied parameters in all studied groups, normal control group, reactive group, and APLS patients’ group

From: Insight into antiphospholipid syndrome: the role and clinical utility of neutrophils extracellular traps formation

 

All studied groups

Control group

Reactive Group

APLS

r

P-value

r

P-value

r

P-value

r

P-value

Age (years)

0.177

0.098

0.054

0.820

0.009

0.971

0.234

0.105

HB g/dL

−0.352

0.001**

−0.064

0.789

− 0.061

0.799

0.181

0.213

WBCs (×103/ul)

0.230

0.030*

0.292

0.211

0.031

0.898

0.120

0.410

NE (×103/ul)

0.226

0.034*

0.338

0.144

0.011

0.962

0.041

0.780

N/L ratio

0.164

0.125

0.293

0.210

−0.013

0.956

−0.129

0.377

PLT (×103/ul)

−0.189

0.076

0.232

0.324

−0.160

0.500

0.042

0.774

PT (min)

0.218

0.040*

0.035

0.883

−0.211

0.373

0.370

0.009**

INR

0.341

0.001**

0.233

0.322

−0.111

0.651

0.315

0.028*

PTT (min)

0.137

0.210

0.108

0.652

−0.246

0.296

−0.084

0.585

CRP (mg/dL)

0.167

0.132

0.287

0.220

−0.297

0.203

−0.457

0.002**

ESR (mm/hour)

0.349

0.001**

−0.082

0.731

−0.043

0.858

0.119

0.415

Histones (ng/ml)

0.836

0.000**

0.161

0.497

0.659

0.002**

0.798

0.000**

  1. P-value > 0.05: Non-significant; P-value < 0.05*: Significant; P-value < 0.01**: Highly significant, analysis was done by Spearman correlation coefficient